Efficacy and safety of PARP inhibitor maintenance therapy in elderly ovarian cancer patients: a real-world single-center retrospective cohort study - Quiz - MDSpire

Efficacy and safety of PARP inhibitor maintenance therapy in elderly ovarian cancer patients: a real-world single-center retrospective cohort study

  • By

  • Jingjing Lu

  • Xuelian Song

  • Chen Zhang

  • Yi Zhu

  • Huarui Yang

  • Yi Li

  • June 8, 2026

  • 0 min

Share

Original Source(s)

Efficacy and safety of PARP inhibitor maintenance therapy in elderly ovarian cancer patients: a real-world single-center retrospective cohort study

  • by Jingjing Lu, Xuelian Song, Chen Zhang, Yi Zhu, Huarui Yang, Yi Li

  • June 8, 2026

Related Content

The gastrin-releasing peptide receptor in oncology: a comprehensive review of recent advances in targeted radionuclide theranostics

Predicting 5-Year Mortality in Non–Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study

Rearming mesenchymal stem cells with engineering strategies to combat cancer